Our management team

Fernando Andreu CEO

Ole Thastrup CSO and Deputy CEO

Kenneth Graabek Johansen Chief Financial Officer

Henrik Harling Chief Medical Officer

Grith Hagel Chief Operating Officer

Jürgen Kupper Managing director (2cureX GmbH)

Jesper Floyd Kristiansen VP Business Development Europe

Mark C. Gray Director of Communications

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.